About Lutonix
Lutonix is a company based in Minneapolis (United States) founded in 2007 by Lixiao Wang was acquired by CR Bard in December 2011. Lutonix has raised $35 million across 3 funding rounds from investors including CR Bard, Versant Ventures and Delphi Ventures. Lutonix operates in a competitive market with competitors including Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
- Headquarter Minneapolis, United States
- Founders Lixiao Wang
- SectorsHealthcare
- Website lutonix.com
- Acquired by CR Bard (Dec 2011)
- Legal Name Lutonix Inc
Funding Insights of Lutonix
Lutonix has successfully raised a total of $35M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $10 million completed in December 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $35M
- Total Rounds 3
- Last Round Series B — $10M
- First Round $5M
(Jun 2007)
- Investors Count 4
All 3 funding rounds of Lutonix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2010 | $10M | Series B | – | – | – |
| Oct 2008 | $20M | Series B | – | Versant Ventures | |
| Jun 2007 | $5M | Series A | – | – |
5 investors in total: 5 institutional.
Investors in Lutonix
Lutonix has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include CR Bard, Versant Ventures and Delphi Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999. | – | versantventures.com | - | |
Investments are made in life sciences firms across all stages. | – | delphiventures.com | Menlo Park, United States | |
VC firm that focuses on early stage investments in the US | – | usvp.com | Menlo Park, United States | |
- | – | rivervest.com | - | |
Products for vascular, urology, oncology, and surgical specialties | 1907 | crbard.com | Murray, United States |
Investor details for Lutonix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lutonix
1 people are tracked at Lutonix (1 in leadership).
| Name | Role | Group |
|---|---|---|
Lixiao Wang | Co-Founder & CTO | Leadership |
Complete people profiles for Lutonix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lutonix
4 dated milestones of Lutonix across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Lutonix is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Series B, of $10.0M.
- Exit Acquired by CR Bard.
Competitors of Lutonix
Lutonix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| csi360.com | 1989 | Saint Paul, United States | $121.34M | 780 | Devices for treating peripheral and coronary vascular disease are developed. | |
| contegomedical.com | 2005 | Raleigh, United States | $66.01M | – | Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature | |
| angioscore.com | 2003 | Fremont, United States | $87M | – | Scoring balloon catheters for coronary and peripheral angioplasty are developed. | |
| echopointmedical.com | 2018 | London, United Kingdom | $9.74M | 8 | Smart devices for monitoring coronary artery disease are developed. | |
| shapemem.com | 2009 | Santa Clara, United States | $77.27M | 37 | Embolization devices are developed using Shape Memory Polymer foams. | |
| limflow.com | 2012 | Paris, France | $97.45M | – | Developer a system for venous arterialization of the lower limbs | |
| terumo.com | 1921 | Somerset, United States | – | – | Portfolio of medical devices for interventional cardiology is provided. | |
| vasc.com | 1997 | Minneapolis, United States | $12M | 562 | Products for vascular diagnostics and interventional procedures are developed. | |
| ev3.net | 2000 | Plymouth, United States | $58.8M | 1,307 | Surgical products for treatment of Peripheral vascular & Neurovascular diseases | |
| vascular-flow.com | 1998 | Dundee, United Kingdom | $16.79M | 10 | Vascular devices are developed using spiral laminar flow technology. |
Detailed competitors of Lutonix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Lutonix
10 companies that operate in the same segment as Lutonix (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lutonix
Lutonix was founded in 2007.
Lutonix is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Lutonix is a funded company, having raised a total of $35M across 3 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Jun 2007.
Lutonix was founded in 2007 in Minneapolis, United States, focusing on the medical device sector. Drug-coated balloon catheters are offered for treating peripheral and coronary artery lesions. Paclitaxel, an anti-proliferative agent, is delivered by the catheters to inhibit restenosis. The company was acquired by Bard in 2011, with operations centered on cardiovascular interventions.
Lutonix's top competitors include Contego Medical, Limflow and Shape Memory Medical.
Lutonix has 5 investors. Key investors include CR Bard, Versant Ventures, Delphi Ventures, USVP, and RiverVest Venture Partners.
Lutonix operates through Lutonix Inc.
Yes. Lutonix was acquired by CR Bard in December 2011.